StockMacro
Menu

Albemarle

$79.70 -54% in 6 monthsMarket cap $9.4B

ALB on XNYS, Materials, Albemarle Corporation, job postings

Measures activity, not value. Not investment advice.

Revenue rose 19% to $1.6B last quarter but shares are down 32% over 12 months.

  • BadShort interest at 11% of shares, up 1.2% on the prior report
  • BadInstitutional holders fell to 850 from 919 last quarter

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Albemarle is one of the world's largest lithium producers. In the lithium industry, the majority of demand comes from batteries, where lithium is used as the energy storage material, particularly in electric vehicles. Albemarle is a fully integrated lithium producer. Its upstream resources include salt brine deposits in Chile and the US and two hard rock mines in Australia, both of which are joint ventures. The company operates lithium refining plants in Chile, the US, Australia, and China. Albemarle is a global leader in the production of bromine, used in flame retardants.

Industry
Plastic materials, synth resins & nonvulcan elastomers (Materials)
Employees
7,800
Website
albemarle.com
Listed
NYSE, US
Last results
4 Nov 2026
Next results
expected around 10 Feb 2027 (an estimate: a year ago it reported on 11 Feb 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $1.6B, net income $296.8M.
Quarter to 31 Dec 2021: revenue $894.2M, net income -$3.8MQuarter to 31 Dec 2021: revenue $894.2M, net income -$3.8MQuarter to 31 Mar 2022: revenue $1.1B, net income $253.4MQuarter to 31 Mar 2022: revenue $1.1B, net income $253.4MQuarter to 30 Jun 2022: revenue $1.5B, net income $406.8MQuarter to 30 Jun 2022: revenue $1.5B, net income $406.8MQuarter to 30 Sep 2022: revenue $2.1B, net income $897.2MQuarter to 30 Sep 2022: revenue $2.1B, net income $897.2MQuarter to 31 Dec 2022: revenue $2.6B, net income $1.1BQuarter to 31 Dec 2022: revenue $2.6B, net income $1.1BQuarter to 31 Mar 2023: revenue $2.6B, net income $1.2BQuarter to 31 Mar 2023: revenue $2.6B, net income $1.2BQuarter to 30 Jun 2023: revenue $2.4B, net income $650.0MQuarter to 30 Jun 2023: revenue $2.4B, net income $650.0MQuarter to 30 Sep 2023: revenue $2.3B, net income $302.5MQuarter to 30 Sep 2023: revenue $2.3B, net income $302.5MQuarter to 31 Dec 2023: revenue $2.4B, net income -$617.7MQuarter to 31 Dec 2023: revenue $2.4B, net income -$617.7MQuarter to 31 Mar 2024: revenue $1.4B, net income $2.4MQuarter to 31 Mar 2024: revenue $1.4B, net income $2.4MQuarter to 30 Jun 2024: revenue $1.4B, net income -$188.2MQuarter to 30 Jun 2024: revenue $1.4B, net income -$188.2MQuarter to 30 Sep 2024: revenue $1.4B, net income -$1.1BQuarter to 30 Sep 2024: revenue $1.4B, net income -$1.1BQuarter to 31 Dec 2024: revenue $1.2B, net income $75.3MQuarter to 31 Dec 2024: revenue $1.2B, net income $75.3MQuarter to 31 Mar 2025: revenue $1.1B, net income $41.3MQuarter to 31 Mar 2025: revenue $1.1B, net income $41.3MQuarter to 30 Jun 2025: revenue $1.3B, net income $22.9MQuarter to 30 Jun 2025: revenue $1.3B, net income $22.9MQuarter to 30 Sep 2025: revenue $1.3B, net income -$160.7MQuarter to 30 Sep 2025: revenue $1.3B, net income -$160.7MQuarter to 31 Dec 2025: revenue $1.4B, net income -$414.2MQuarter to 31 Dec 2025: revenue $1.4B, net income -$414.2MQuarter to 31 Mar 2026: revenue $1.4B, net income $319.1MQuarter to 31 Mar 2026: revenue $1.4B, net income $319.1MQuarter to 30 Jun 2026: revenue $1.7B, net income $480.0MQuarter to 30 Jun 2026: revenue $1.7B, net income $480.0MQuarter to 30 Sep 2026: revenue $1.6B, net income $296.8MQuarter to 30 Sep 2026: revenue $1.6B, net income $296.8M
31 Dec 2021RevenueNet incomeNet losstallest bar $2.6B30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$1.6B$296.8M
30 Jun 2026$1.7B$480.0M
31 Mar 2026$1.4B$319.1M
31 Dec 2025$1.4B-$414.2M
30 Sep 2025$1.3B-$160.7M
30 Jun 2025$1.3B$22.9M
31 Mar 2025$1.1B$41.3M
31 Dec 2024$1.2B$75.3M
30 Sep 2024$1.4B-$1.1B
30 Jun 2024$1.4B-$188.2M
31 Mar 2024$1.4B$2.4M
31 Dec 2023$2.4B-$617.7M
30 Sep 2023$2.3B$302.5M
30 Jun 2023$2.4B$650.0M
31 Mar 2023$2.6B$1.2B
31 Dec 2022$2.6B$1.1B
30 Sep 2022$2.1B$897.2M
30 Jun 2022$1.5B$406.8M
31 Mar 2022$1.1B$253.4M
31 Dec 2021$894.2M-$3.8M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $6.2B $4.9B
Revenue growthRevenue of the last 12 months compared with the 12 months before. +24% +7.1%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. $681.6M -$21.2M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). $4.13 -$1.59
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. 25.8% 12.3% 25.8%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. 10.0% -2.9% 7.4%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. 11.1% -0.4% 5.3%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. 6.6% 5.2%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. – –
CashCash, cash equivalents and short-term investments on the latest balance sheet. $1.8B $1.9B
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $1.9B $3.6B
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). $35.4M $1.7B
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 0.18 0.71
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $89.33
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. 13.8 27.0
P/SPrice to sales: market cap divided by revenue of the last 12 months. 1.5 1.9
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. 1.5 1.5
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 0.89 1.4
Dividend yieldDividends per share declared in the latest fiscal year divided by the share price. 2.0% 2.0%

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
AlbemarleALB (this company) $9.4B13.81.5+24%11.1%
Eastman ChemicalEMN $6.7B10.40.74+0.3%7.2%
HexcelHXL $5.5B32.22.7+7.6%8.5%
DuPont de NemoursDD $19.3B64.02.7+3.3%4.2%
DowDOW $21.0B––––
AvientAVNT $3.9B21.81.2+5.2%5.3%

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

–

No data for this company

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

-7.5%

850 13F filers vs 919

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

97%

114.2M shares held by 13F filers (30 Sep 2026) of 118.0M outstanding (28 Oct 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

11%

12.4M shares sold short (30 Oct 2026) of 118.0M outstanding (28 Oct 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

5.3

12.4M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

+1.2%

12.3M shares sold short in the report before, 12.4M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

58%

58% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 59%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

–

We do not track this company's careers site yet.

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

We do not track this company's careers site yet.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

–

No data for this company

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

+19%

$1.6B vs $1.3B (quarter ended 30 Sep 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

–

No data for this company

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

$24K

the 12 months before: $0

Lobbying What the company reported spending on federal lobbying over the last four quarters.

$2.3M

4 quarters, $

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

44

44 articles in the last 7 days; its usual week has 8 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

5.5×

44 articles in the last 7 days; its usual week has 8.

Price $79.70 on 20 Nov 2026, -32% over 12 months (12-month range $79.70 to $215.62)

  • Sharp change
  • 8-K and other filings
  • Federal award
  • Lobbying filing
Insider net buying (open market). Insiders sold a net $7.4M in the last 12 months (the 12 months before: -$284K).
H-1B/E-3 applications certified. H-1B/E-3 applications certified: 2 published in the last 12 months, -75% on the 12 months before.
Revenue per quarter. Revenue $1.6B in the latest quarter, +19% on a year earlier.
Capital spending per quarter. Capital spending $80.4M in the latest quarter.
Institutional holders (13F filers). 850 13F filers reported holding it in the latest 13F quarter, +18% on a year earlier.
Federal obligations. Federal obligations: $24K published in the last 12 months (none in the 12 months before).
Lobbying spend. Lobbying spend: $2.3M published in the last 12 months, +6.1% on the 12 months before.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
30 Oct 20268-K and other filingsA major agreement ended
3 Sep 20268-K and other filingsDirector or officer change
21 Aug 20268-K and other filingsDirector or officer change
23 Jul 20268-K and other filingsDirector or officer change
5 Jun 20268-K and other filingsDirector or officer change
19 May 2026Sharp changeMany funds opening a new position: many funds opening a new position, 165 vs usual 87.50 (2026-03-31); 2.1x the same period a year earlier
8 May 20268-K and other filingsDirector or officer change
17 Apr 20268-K and other filingsDirector or officer change
6 Mar 20268-K and other filingsCompleted an acquisition or asset sale
4 Mar 20268-K and other filingsDirector or officer change
17 Feb 2026Sharp changeMany funds opening a new position: many funds opening a new position, 191 vs usual 82.50 (2025-12-31); 2.5x the same period a year earlier
12 Dec 20258-K and other filingsDirector or officer change
12 Dec 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
18 Nov 2025Sharp changeMany funds opening a new position: many funds opening a new position, 130 vs usual 82.50 (2025-09-30); 1.5x the same period a year earlier
27 Oct 20258-K and other filingsAsset write-down (impairment)
12 Aug 20258-K and other filingsDirector or officer change
4 Aug 20258-K and other filingsDirector or officer change
4 Aug 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
1 Jul 2025Sharp changeShort interest spike: short interest spike, 18.7M vs usual 13.2M (2025-06-13); 1.1x the same period a year earlier
17 Jun 2025Sharp changeShort interest spike: short interest spike, 18.6M vs usual 13.2M (2025-05-30); 1.2x the same period a year earlier
3 Jun 2025Sharp changeShort interest spike: short interest spike, 18.8M vs usual 13.2M (2025-05-15); 1.4x the same period a year earlier
18 Apr 2025Lobbying filingnew lobbying registration (BGR GOVERNMENT AFFAIRS)
31 Oct 20248-K and other filingsDirector or officer change
7 Oct 20248-K and other filingsDirector or officer change
7 Oct 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
13 Feb 2024Sharp changeShort interest spike: short interest spike, 13.9M vs usual 6.8M (2024-01-31); 3.5x the same period a year earlier
30 Jan 2024Sharp changeShort interest spike: short interest spike, 14.1M vs usual 6.5M (2024-01-12); 3.9x the same period a year earlier
23 Jan 2024Sharp changeLobbying spend jump: lobbying spend jump, 430K vs usual 25K (2023-12-31); 17.2x the same period a year earlier
16 Jan 2024Sharp changeShort interest spike: short interest spike, 14.1M vs usual 6.5M (2023-12-29); 4.2x the same period a year earlier
12 Dec 2023Sharp changeShort interest spike: short interest spike, 13.1M vs usual 6.3M (2023-11-30); 6.2x the same period a year earlier
26 Oct 20238-K and other filingsDirector or officer change
26 Oct 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
8 Aug 2023Sharp changeQuarterly capital spending jump: quarterly capital spending jump, 503.7M vs usual 285.9M (2023-06-30); 1.9x the same period a year earlier
18 Jul 2023Sharp changeFederal obligations jump: federal obligations jump, 149.7M vs usual 0 in the same month of earlier years (2023-06-01..2023-06-30)
16 Jul 2023Federal awardnew Department of Energy grant DEMS0000001 ($149.7M)
3 Jul 2023Lobbying filinglobbying engagement terminated (in-house)
3 Jul 2023Sharp changeLobbying on a new issue: lobbying on a new issue: FOR, MAN (2023-06-30)
13 Jun 2023Sharp changeShort interest spike: short interest spike, 6.5M vs usual 2.6M (2023-05-31); 3.5x the same period a year earlier
30 May 2023Sharp changeShort interest spike: short interest spike, 6.0M vs usual 2.5M (2023-05-15); 3.3x the same period a year earlier
16 May 2023Sharp changeShort interest spike: short interest spike, 5.5M vs usual 2.5M (2023-04-28); 3.7x the same period a year earlier
16 May 2023Sharp changeClustered insider buying: clustered insider buying (3 independent filers, 3 filing(s) in 30 days, value_usd total 1.5M)
9 May 2023Sharp changeQuarterly revenue change: quarterly revenue change, 2.6B vs usual 1.0B (2023-03-31); 2.3x the same period a year earlier
2 May 2023Sharp changeShort interest spike: short interest spike, 6.9M vs usual 2.4M (2023-04-14); 4.4x the same period a year earlier
2 May 20238-K and other filingsDirector or officer change
18 Apr 2023Sharp changeShort interest spike: short interest spike, 6.2M vs usual 2.3M (2023-03-31); 4.2x the same period a year earlier
28 Mar 2023Sharp changeShort interest spike: short interest spike, 5.5M vs usual 2.2M (2023-03-15); 3.3x the same period a year earlier
20 Mar 20238-K and other filingsDirector or officer change
14 Mar 2023Sharp changeShort interest spike: short interest spike, 5.3M vs usual 2.1M (2023-02-28); 2.9x the same period a year earlier
28 Feb 2023Sharp changeShort interest spike: short interest spike, 4.0M vs usual 2.1M (2023-02-15); 2.4x the same period a year earlier
24 Feb 20238-K and other filingsDirector or officer change
24 Feb 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
21 Feb 2023Sharp changeQuarterly revenue change: quarterly revenue change, 2.6B vs usual 886.7M (2022-12-31); 2.9x the same period a year earlier
14 Feb 2023Sharp changeShort interest spike: short interest spike, 4.0M vs usual 2.1M (2023-01-31); 2.3x the same period a year earlier
31 Jan 2023Sharp changeShort interest spike: short interest spike, 3.6M vs usual 2.1M (2023-01-13); 1.7x the same period a year earlier
17 Jan 2023Sharp changeShort interest spike: short interest spike, 3.4M vs usual 2.1M (2022-12-30); 1.7x the same period a year earlier
8 Nov 2022Sharp changeQuarterly revenue change: quarterly revenue change, 2.1B vs usual 854.9M (2022-09-30); 2.5x the same period a year earlier
31 Oct 20228-K and other filingsDirector or officer change
31 Oct 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
9 Aug 2022Sharp changeQuarterly revenue change: quarterly revenue change, 1.5B vs usual 829.9M (2022-06-30); 1.9x the same period a year earlier
10 May 2022Sharp changeQuarterly revenue change: quarterly revenue change, 1.1B vs usual 801.6M (2022-03-31); 1.4x the same period a year earlier
9 Mar 20228-K and other filingsDirector or officer change
28 Feb 20228-K and other filingsDirector or officer change
24 Feb 20228-K and other filingsDirector or officer change
24 Feb 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
Insider net buying (open market)
Month from 1 Dec 2021: -$349K published
Month from 1 Jan 2022: -$920K published
Month from 1 Feb 2022: $1.2M published
Month from 1 Sep 2022: -$4.7M published
Month from 1 Oct 2022: -$609K published
Month from 1 Nov 2022: -$4.3M published
Month from 1 Dec 2022: -$631K published
Month from 1 Jan 2023: -$378K published
Month from 1 Mar 2023: -$1.5M published
Month from 1 May 2023: $1.5M published
Month from 1 Nov 2023: $167K published
Month from 1 May 2024: -$309K published
Month from 1 Nov 2024: -$112K published
Month from 1 Dec 2024: -$255K published
Month from 1 Oct 2025: -$29K published
Month from 1 Feb 2026: -$2.3M published
Month from 1 Mar 2026: -$2.0M published
Month from 1 May 2026: -$3.0M published
H-1B/E-3 applications certified
Quarter from 1 Apr 2022: 1 published
Quarter from 1 Jul 2022: 3 published
Quarter from 1 Oct 2022: 1 published
Quarter from 1 Apr 2023: 1 published
Quarter from 1 Jul 2023: 5 published
Quarter from 1 Oct 2023: 6 published
Quarter from 1 Jul 2024: 12 published
Quarter from 1 Apr 2025: 1 published
Quarter from 1 Jul 2025: 6 published
Quarter from 1 Oct 2025: 1 published
Quarter from 1 Jan 2026: 1 published
Quarter from 1 Apr 2026: 1 published
Revenue per quarter
Quarter ended 31 Dec 2021: $894.2M, +1.7% on a year earlier; public on 23 Feb 2022
Quarter ended 31 Mar 2022: $1.1B, +36% on a year earlier; public on 5 May 2022
Quarter ended 30 Jun 2022: $1.5B, +91% on a year earlier; public on 4 Aug 2022
Quarter ended 30 Sep 2022: $2.1B, +152% on a year earlier; public on 3 Nov 2022
Quarter ended 31 Dec 2022: $2.6B, +193% on a year earlier; public on 16 Feb 2023
Quarter ended 31 Mar 2023: $2.6B, +129% on a year earlier; public on 4 May 2023
Quarter ended 30 Jun 2023: $2.4B, +60% on a year earlier; public on 3 Aug 2023
Quarter ended 30 Sep 2023: $2.3B, +10% on a year earlier; public on 2 Nov 2023
Quarter ended 31 Dec 2023: $2.4B, -10% on a year earlier; public on 16 Feb 2024
Quarter ended 31 Mar 2024: $1.4B, -47% on a year earlier; public on 2 May 2024
Quarter ended 30 Jun 2024: $1.4B, -40% on a year earlier; public on 1 Aug 2024
Quarter ended 30 Sep 2024: $1.4B, -41% on a year earlier; public on 7 Nov 2024
Quarter ended 31 Dec 2024: $1.2B, -48% on a year earlier; public on 13 Feb 2025
Quarter ended 31 Mar 2025: $1.1B, -21% on a year earlier; public on 1 May 2025
Quarter ended 30 Jun 2025: $1.3B, -7.0% on a year earlier; public on 5 Aug 2025
Quarter ended 30 Sep 2025: $1.3B, -3.5% on a year earlier; public on 6 Nov 2025
Quarter ended 31 Dec 2025: $1.4B, +16% on a year earlier; public on 12 Feb 2026
Quarter ended 31 Mar 2026: $1.4B, +33% on a year earlier; public on 7 May 2026
Quarter ended 30 Jun 2026: $1.7B, +31% on a year earlier; public on 6 Aug 2026
Quarter ended 30 Sep 2026: $1.6B, +19% on a year earlier; public on 5 Nov 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $300.9M, +31% on a year earlier; public on 23 Feb 2022
Quarter ended 31 Mar 2022: $231.7M, +29% on a year earlier; public on 5 May 2022
Quarter ended 30 Jun 2022: $270.9M, +25% on a year earlier; public on 4 Aug 2022
Quarter ended 30 Sep 2022: $313.3M, +22% on a year earlier; public on 3 Nov 2022
Quarter ended 31 Dec 2022: $445.7M, +48% on a year earlier; public on 16 Feb 2023
Quarter ended 31 Mar 2023: $415.6M, +79% on a year earlier; public on 4 May 2023
Quarter ended 30 Jun 2023: $503.7M, +86% on a year earlier; public on 3 Aug 2023
Quarter ended 30 Sep 2023: $545.9M, +74% on a year earlier; public on 2 Nov 2023
Quarter ended 31 Dec 2023: $684.1M, +53% on a year earlier; public on 16 Feb 2024
Quarter ended 31 Mar 2024: $579.3M, +39% on a year earlier; public on 2 May 2024
Quarter ended 30 Jun 2024: $447.6M, -11% on a year earlier; public on 1 Aug 2024
Quarter ended 30 Sep 2024: $303.1M, -44% on a year earlier; public on 7 Nov 2024
Quarter ended 31 Dec 2024: $355.7M, -48% on a year earlier; public on 13 Feb 2025
Quarter ended 31 Mar 2025: $182.6M, -68% on a year earlier; public on 1 May 2025
Quarter ended 31 Dec 2025: $155.4M, -56% on a year earlier; public on 12 Feb 2026
Quarter ended 31 Mar 2026: $98.7M, -46% on a year earlier; public on 7 May 2026
Quarter ended 30 Jun 2026: $71.7M; public on 6 Aug 2026
Quarter ended 30 Sep 2026: $80.4M; public on 5 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 775; public on 14 Feb 2022
31 Mar 2022 report: 795; public on 16 May 2022
30 Jun 2022 report: 821; public on 15 Aug 2022
30 Sep 2022 report: 869; public on 14 Nov 2022
31 Dec 2022 report: 917; public on 14 Feb 2023
31 Mar 2023 report: 943; public on 15 May 2023
30 Jun 2023 report: 926; public on 14 Aug 2023
30 Sep 2023 report: 908; public on 14 Nov 2023
31 Dec 2023 report: 858; public on 14 Feb 2024
31 Mar 2024 report: 854; public on 15 May 2024
30 Jun 2024 report: 788; public on 14 Aug 2024
30 Sep 2024 report: 755; public on 14 Nov 2024
31 Dec 2024 report: 758; public on 14 Feb 2025
31 Mar 2025 report: 731; public on 15 May 2025
30 Jun 2025 report: 691; public on 14 Aug 2025
30 Sep 2025 report: 720; public on 14 Nov 2025
31 Dec 2025 report: 858; public on 17 Feb 2026
31 Mar 2026 report: 957; public on 15 May 2026
30 Jun 2026 report: 919; public on 14 Aug 2026
30 Sep 2026 report: 850; public on 16 Nov 2026
Federal obligations
Month from 1 Dec 2021: -$1K published
Month from 1 Jan 2022: -$240 published
Month from 1 May 2022: $4K published
Month from 1 Jun 2022: -$1K published
Month from 1 Sep 2022: $0 published
Month from 1 Oct 2022: $5K published
Month from 1 Jan 2023: $0 published
Month from 1 Feb 2023: -$1K published
Month from 1 Apr 2023: $0 published
Month from 1 May 2023: $8K published
Month from 1 Jul 2023: $149.7M published
Month from 1 Dec 2023: $0 published
Month from 1 Jan 2024: $0 published
Month from 1 Jul 2024: $12K published
Month from 1 Feb 2025: $0 published
Month from 1 Jun 2025: $0 published
Month from 1 Jan 2026: -$1K published
Month from 1 Jun 2026: $26K published
Lobbying spend
Quarter from 1 Oct 2021: $25K published
Quarter from 1 Jan 2022: $25K published
Quarter from 1 Apr 2022: $25K published
Quarter from 1 Jul 2022: $25K published
Quarter from 1 Oct 2022: $25K published
Quarter from 1 Jan 2023: $25K published
Quarter from 1 Oct 2023: $580K published
Quarter from 1 Jan 2024: $860K published
Quarter from 1 Apr 2024: $550K published
Quarter from 1 Jul 2024: $540K published
Quarter from 1 Oct 2024: $540K published
Quarter from 1 Jan 2025: $460K published
Quarter from 1 Apr 2025: $530K published
Quarter from 1 Jul 2025: $630K published
Quarter from 1 Oct 2025: $510K published
Quarter from 1 Jan 2026: $640K published
Quarter from 1 Apr 2026: $670K published
Quarter from 1 Jul 2026: $520K published
Quarter from 1 Oct 2026: $430K published

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is insider open-market selling (USD, Form 4) at $3.0M (19 May 2026), 27× its normal reading; higher than 85% of its own history.
  • Insider net buying (open market): Insiders sold a net $7.4M in the last 12 months (the 12 months before: -$284K).
  • H-1B/E-3 applications certified: H-1B/E-3 applications certified: 2 published in the last 12 months, -75% on the 12 months before.
  • Revenue per quarter: Revenue $1.6B in the latest quarter, +19% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

Insider trades

All 97 insider trades

No trades in the last 90 days; the latest was filed 19 May 2026. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
19 May 2026J Kent MastersChairman & CEOSell16,393$183.72$3.0MForm 4
12 Mar 2026J Kent MastersChairman & CEOSell11,783$170.81$2.0MForm 4
23 Feb 2026Eric NorrisChief Commercial OfficerSell5,692$165.45$942KForm 4
18 Feb 2026Melissa H. AndersonChief Bus..Transformation Off.Sell8,454$163.71$1.4MForm 4
28 Oct 2025Ander C. KrupaGeneral Counsel & SecSell172$105.00$18KForm 4
14 Oct 2025Ander C. KrupaGeneral Counsel & SecSell116$95.00$11KForm 4
6 Dec 2024J Kent MastersChairman & CEOSell2,525$101.12$255KForm 4
20 Nov 2024Netha N. JohnsonChief Operations OfficerSell1,060$106.04$112KForm 4

850 institutions reported shares at the end of Q3 2026, 97% of the shares outstanding; 95 opened a position, 167 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
BlackRock, Inc.10.0M8.50%$1.1B+527K+5.5%
Capital World Investors9.7M8.18%$1.0B-252K-2.5%
Vanguard Capital Management LLC7.7M6.55%$818.2M+32K+0.4%
Vanguard Portfolio Management LLC6.5M5.47%$683.0M+20K+0.3%
State Street Corp6.3M5.36%$671.4M+823K+15%
FMR LLC (Fidelity)4.6M3.91%$487.6M+1.9M+72%
Franklin Templeton Inc3.4M2.86%$320.8M+2.9M+602%
Geode Capital Management, LLC3.1M2.66%$331.7M+12K+0.4%
Morgan Stanley3.1M2.58%$322.7M+155K+5.3%
Primecap Management Co2.7M2.26%$282.6M+20K+0.7%

Federal contracts

All 2 federal contracts

No new award in 12 months; the latest was signed 15 Jun 2023. New awards only; later changes to an award are not listed.

SignedAgencyAmountWhat forSource
15 Jun 2023Department of Energy$149.7Mup to $394.1MNEW AWARD TO ALBEMARLE U.S. INC. AWARD NUMBER: DE-MS0000001 PROJECT TITLE: BIPARTISAN INFRASTRUCTURE LAW (BIL) - KINGS MOUNTAIN LITHIUM MATERIALS PROCESSING PLANTGrantUSAspending
12 May 2020Department of Energy$1.4Mup to $2.5MNEW AWARD NUMBER DE-EE0009094 TO ALBEMARLE CORPORATION, TITLED ''THIN-FILM LITHIUM METAL MANUFACTURE BY ROOM-TEMPERATURE ELECTRODEPOSITION.''GrantUSAspending

Company events

All 58 company events

In 12 months: 8 director or officer changes, 2 major agreements, 1 completed deal, 1 agreement ended. Results releases and routine reports are left out.

FiledWhat happenedSource
30 Oct 2026Signed a major agreement; A major agreement endedSame filing: took on new debt, changed its bylaws or fiscal year8-K
3 Sep 2026Director or officer change8-K
21 Aug 2026Director or officer change8-K
23 Jul 2026Director or officer change8-K
5 Jun 2026Director or officer change8-K
8 May 2026Director or officer changeSame filing: shareholder vote results8-K
17 Apr 2026Director or officer change8-K
25 Mar 2026Signed a major agreement8-K

Reported lobbying spend: $430K in Q3 2026, $520K in Q2 2026. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.

DateChangeLobbying firmIssueSource
1 Apr 2025NewBGR Government Affairsfor Albemarle CorporationProvide strategic counsel and advocate on issues relating to critical minerals, trade, taxes, and defenseTrade, Taxation, DefenseFiling
1 Apr 2023EndedAlbemarle Corporationits own lobbyistsNot statedFiling
2 Oct 2020EndedMayer Brown LLPfor Albemarle CorporationNot statedFiling
4 Jun 2019NewMayer Brown LLPfor Albemarle CorporationIssues related to visas.ImmigrationFiling
4 Jun 2015EndedLevine & Companyfor Rockwood HoldingsIncreased use of lithiumCHMFiling
31 Dec 2011EndedKinghorn, Hilbert & Associatesfor Albemarle CorporationFY2012 Defense Appropriations and Authorization BillsDefense, BudgetFiling
3 Oct 2011NewLevine & Companyfor Rockwood HoldingsIncreased use of lithiumCHMFiling
1 Apr 2010EndedHunton Andrews Kurth LLP (Formerly Hunton & Williams LLP)for Albemarle CorporationNot statedFiling

The 5 newest of 653 articles that name the company.

Timeline

Several things at once

Two or more unrelated kinds of records unusual within 30 days

23 Jan 2024confirmed

Confirmed across sources Lobbying and Short interest and volume

Albemarle (ALB): had 14.1M shares sold short in the 29 Dec 2023 report, 4.2× the same report last year, while it reported $430K of lobbying spend for the quarter ended 31 Dec 2023, 17× the same quarter last year. Two unrelated kinds of activity within 28 days.

  • Short interest and volume: Short interest spike, became public on 11 Jan 2024
  • Lobbying: Lobbying spend jump, became public on 19 Jan 2024
  • Short interest and volume: Short interest spike, became public on 25 Jan 2024
  • Short interest and volume: Short interest spike, became public on 10 Feb 2024
2022-12-30: 3.4M2023-01-13: 3.6M2023-01-31: 4.0M2023-02-15: 4.0M2023-02-28: 5.3M2023-03-15: 5.5M2023-03-31: 6.2M2023-04-14: 6.9M2023-04-28: 5.5M2023-05-15: 6.0M2023-05-31: 6.5M2023-06-15: 6.6M2023-06-30: 7.5M2023-07-14: 6.4M2023-07-31: 5.9M2023-08-15: 6.5M2023-08-31: 7.7M2023-09-15: 8.5M2023-09-29: 8.8M2023-10-13: 9.2M2023-10-31: 9.0M2023-11-15: 11.5M2023-11-30: 13.1M2023-12-15: 12.1M2023-12-29: 14.1M
The 29 Dec 2023 report against the 24 reports before it. this reportearliernormal: 6.5M
See the evidence (4 changes)

Short interest and volume: Short interest spike became public on 11 Jan 2024

Albemarle had 14.1M shares sold short in the 29 Dec 2023 report, 4.2× the same report last year.

This period
14.1M (the 29 Dec 2023 report)
Normal report (median of 24 earlier)
6.5M
Typical spread (median absolute deviation)
1.2M
How far from its usual level
+4.4
Same report last year
3.4M
History used
2,191 days
2022-12-30: 3.4M2023-01-13: 3.6M2023-01-31: 4.0M2023-02-15: 4.0M2023-02-28: 5.3M2023-03-15: 5.5M2023-03-31: 6.2M2023-04-14: 6.9M2023-04-28: 5.5M2023-05-15: 6.0M2023-05-31: 6.5M2023-06-15: 6.6M2023-06-30: 7.5M2023-07-14: 6.4M2023-07-31: 5.9M2023-08-15: 6.5M2023-08-31: 7.7M2023-09-15: 8.5M2023-09-29: 8.8M2023-10-13: 9.2M2023-10-31: 9.0M2023-11-15: 11.5M2023-11-30: 13.1M2023-12-15: 12.1M2023-12-29: 14.1M
the 29 Dec 2023 report24 earlier reportsnormal: 6.5M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Lobbying: Lobbying spend jump became public on 19 Jan 2024

Albemarle reported $430K of lobbying spend for the quarter ended 31 Dec 2023, 17× the same quarter last year.

This period
$430K (the quarter ended 31 Dec 2023)
Normal quarter (median of 8 earlier)
$25K
Typical spread (median absolute deviation)
$0
How far from its usual level
+20.2
Same quarter last year
$25K
History used
5,297 days
2021-12-31: $25K2022-03-31: $25K2022-06-30: $25K2022-09-30: $25K2022-12-31: $25K2023-03-31: $260K2023-06-30: $320K2023-09-30: $430K2023-12-31: $430K
the quarter ended 31 Dec 20238 earlier quartersnormal: $25K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least $100K.

Check it at the source: Senate/House lobbying disclosures (LDA).

Short interest and volume: Short interest spike became public on 25 Jan 2024

Albemarle had 14.1M shares sold short in the 12 Jan 2024 report, 3.9× the same report last year.

This period
14.1M (the 12 Jan 2024 report)
Normal report (median of 24 earlier)
6.5M
Typical spread (median absolute deviation)
1.2M
How far from its usual level
+4.4
Same report last year
3.6M
History used
2,205 days
2023-01-13: 3.6M2023-01-31: 4.0M2023-02-15: 4.0M2023-02-28: 5.3M2023-03-15: 5.5M2023-03-31: 6.2M2023-04-14: 6.9M2023-04-28: 5.5M2023-05-15: 6.0M2023-05-31: 6.5M2023-06-15: 6.6M2023-06-30: 7.5M2023-07-14: 6.4M2023-07-31: 5.9M2023-08-15: 6.5M2023-08-31: 7.7M2023-09-15: 8.5M2023-09-29: 8.8M2023-10-13: 9.2M2023-10-31: 9.0M2023-11-15: 11.5M2023-11-30: 13.1M2023-12-15: 12.1M2023-12-29: 14.1M2024-01-12: 14.1M
the 12 Jan 2024 report24 earlier reportsnormal: 6.5M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 10 Feb 2024

Albemarle had 13.9M shares sold short in the 31 Jan 2024 report, 3.5× the same report last year.

This period
13.9M (the 31 Jan 2024 report)
Normal report (median of 24 earlier)
6.8M
Typical spread (median absolute deviation)
1.3M
How far from its usual level
+3.6
Same report last year
4.0M
History used
2,224 days
2023-01-31: 4.0M2023-02-15: 4.0M2023-02-28: 5.3M2023-03-15: 5.5M2023-03-31: 6.2M2023-04-14: 6.9M2023-04-28: 5.5M2023-05-15: 6.0M2023-05-31: 6.5M2023-06-15: 6.6M2023-06-30: 7.5M2023-07-14: 6.4M2023-07-31: 5.9M2023-08-15: 6.5M2023-08-31: 7.7M2023-09-15: 8.5M2023-09-29: 8.8M2023-10-13: 9.2M2023-10-31: 9.0M2023-11-15: 11.5M2023-11-30: 13.1M2023-12-15: 12.1M2023-12-29: 14.1M2024-01-12: 14.1M2024-01-31: 13.9M
the 31 Jan 2024 report24 earlier reportsnormal: 6.8M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

21 Feb 2023confirmed

Confirmed across sources Government contracts and Insiders and Filings + Financials and Lobbying and Short interest and volume

Albemarle (ALB): reported revenue of $2.6B for the quarter ended 31 Dec 2022, 2.9× the same quarter last year; it also had 6.9M shares sold short in the 14 Apr 2023 report, 4.4× the same report last year; it also had 3 insiders buy $1.5M of its shares on the open market within 30 days (3 filings); it also lobbying on a new issue; and it booked $149.7M in federal contract and grant obligations in June 2023, against none in the same month last year. Five unrelated kinds of activity within 189 days.

  • Short interest and volume: Short interest spike, became public on 26 Jan 2023
  • Short interest and volume: Short interest spike, became public on 10 Feb 2023
  • Financials: Quarterly revenue change, became public on 21 Feb 2023
  • Short interest and volume: Short interest spike, became public on 28 Feb 2023
  • Short interest and volume: Short interest spike, became public on 10 Mar 2023
  • Short interest and volume: Short interest spike, became public on 25 Mar 2023
  • Short interest and volume: Short interest spike, became public on 13 Apr 2023
  • Short interest and volume: Short interest spike, became public on 26 Apr 2023
  • Financials: Quarterly revenue change, became public on 9 May 2023
  • Insiders: Clustered insider buying, became public on 16 May 2023
  • Short interest and volume: Short interest spike, became public on 10 May 2023
  • Short interest and volume: Short interest spike, became public on 25 May 2023
  • Short interest and volume: Short interest spike, became public on 10 Jun 2023
  • Lobbying: Lobbying on a new issue, became public on 3 Jul 2023
  • Government contracts: Federal obligations jump, became public on 16 Jul 2023
  • Financials: Quarterly capital spending jump, became public on 8 Aug 2023
2020-12-31: $879.1M2021-03-31: $829.3M2021-06-30: $773.9M2021-09-30: $830.6M2021-12-31: $894.2M2022-03-31: $1.1B2022-06-30: $1.5B2022-09-30: $2.1B2022-12-31: $2.6B
The quarter ended 31 Dec 2022 against the 8 quarters before it. this quarterearliernormal: $886.7M
See the evidence (16 changes)

Short interest and volume: Short interest spike became public on 26 Jan 2023

Albemarle had 3.6M shares sold short in the 13 Jan 2023 report, 1.7× the same report last year.

This period
3.6M (the 13 Jan 2023 report)
Normal report (median of 24 earlier)
2.1M
Typical spread (median absolute deviation)
289K
How far from its usual level
+3.6
Same report last year
2.1M
History used
1,841 days
2022-01-14: 2.1M2022-01-31: 1.7M2022-02-15: 1.7M2022-02-28: 1.8M2022-03-15: 1.6M2022-03-31: 1.5M2022-04-14: 1.6M2022-04-29: 1.5M2022-05-13: 1.8M2022-05-31: 1.9M2022-06-15: 2.1M2022-06-30: 2.0M2022-07-15: 2.2M2022-07-29: 2.3M2022-08-15: 2.6M2022-08-31: 2.5M2022-09-15: 2.7M2022-09-30: 2.5M2022-10-14: 2.2M2022-10-31: 2.1M2022-11-15: 2.0M2022-11-30: 2.1M2022-12-15: 2.9M2022-12-30: 3.4M2023-01-13: 3.6M
the 13 Jan 2023 report24 earlier reportsnormal: 2.1M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 10 Feb 2023

Albemarle had 4.0M shares sold short in the 31 Jan 2023 report, 2.3× the same report last year.

This period
4.0M (the 31 Jan 2023 report)
Normal report (median of 24 earlier)
2.1M
Typical spread (median absolute deviation)
351K
How far from its usual level
+3.6
Same report last year
1.7M
History used
1,859 days
2022-01-31: 1.7M2022-02-15: 1.7M2022-02-28: 1.8M2022-03-15: 1.6M2022-03-31: 1.5M2022-04-14: 1.6M2022-04-29: 1.5M2022-05-13: 1.8M2022-05-31: 1.9M2022-06-15: 2.1M2022-06-30: 2.0M2022-07-15: 2.2M2022-07-29: 2.3M2022-08-15: 2.6M2022-08-31: 2.5M2022-09-15: 2.7M2022-09-30: 2.5M2022-10-14: 2.2M2022-10-31: 2.1M2022-11-15: 2.0M2022-11-30: 2.1M2022-12-15: 2.9M2022-12-30: 3.4M2023-01-13: 3.6M2023-01-31: 4.0M
the 31 Jan 2023 report24 earlier reportsnormal: 2.1M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Financials: Quarterly revenue change became public on 21 Feb 2023

Albemarle reported revenue of $2.6B for the quarter ended 31 Dec 2022, 2.9× the same quarter last year.

This period
$2.6B (the quarter ended 31 Dec 2022)
Normal quarter (median of 8 earlier)
$886.7M
Typical spread (median absolute deviation)
$85.1M
How far from its usual level
+13.7
Same quarter last year
$894.2M
History used
4,932 days
2020-12-31: $879.1M2021-03-31: $829.3M2021-06-30: $773.9M2021-09-30: $830.6M2021-12-31: $894.2M2022-03-31: $1.1B2022-06-30: $1.5B2022-09-30: $2.1B2022-12-31: $2.6B
the quarter ended 31 Dec 20228 earlier quartersnormal: $886.7M

Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

Check it at the source: SEC EDGAR quarterly reports.

Short interest and volume: Short interest spike became public on 28 Feb 2023

Albemarle had 4.0M shares sold short in the 15 Feb 2023 report, 2.4× the same report last year.

This period
4.0M (the 15 Feb 2023 report)
Normal report (median of 24 earlier)
2.1M
Typical spread (median absolute deviation)
339K
How far from its usual level
+3.8
Same report last year
1.7M
History used
1,874 days
2022-02-15: 1.7M2022-02-28: 1.8M2022-03-15: 1.6M2022-03-31: 1.5M2022-04-14: 1.6M2022-04-29: 1.5M2022-05-13: 1.8M2022-05-31: 1.9M2022-06-15: 2.1M2022-06-30: 2.0M2022-07-15: 2.2M2022-07-29: 2.3M2022-08-15: 2.6M2022-08-31: 2.5M2022-09-15: 2.7M2022-09-30: 2.5M2022-10-14: 2.2M2022-10-31: 2.1M2022-11-15: 2.0M2022-11-30: 2.1M2022-12-15: 2.9M2022-12-30: 3.4M2023-01-13: 3.6M2023-01-31: 4.0M2023-02-15: 4.0M
the 15 Feb 2023 report24 earlier reportsnormal: 2.1M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 10 Mar 2023

Albemarle had 5.3M shares sold short in the 28 Feb 2023 report, 2.9× the same report last year.

This period
5.3M (the 28 Feb 2023 report)
Normal report (median of 24 earlier)
2.1M
Typical spread (median absolute deviation)
340K
How far from its usual level
+6.3
Same report last year
1.8M
History used
1,887 days
2022-02-28: 1.8M2022-03-15: 1.6M2022-03-31: 1.5M2022-04-14: 1.6M2022-04-29: 1.5M2022-05-13: 1.8M2022-05-31: 1.9M2022-06-15: 2.1M2022-06-30: 2.0M2022-07-15: 2.2M2022-07-29: 2.3M2022-08-15: 2.6M2022-08-31: 2.5M2022-09-15: 2.7M2022-09-30: 2.5M2022-10-14: 2.2M2022-10-31: 2.1M2022-11-15: 2.0M2022-11-30: 2.1M2022-12-15: 2.9M2022-12-30: 3.4M2023-01-13: 3.6M2023-01-31: 4.0M2023-02-15: 4.0M2023-02-28: 5.3M
the 28 Feb 2023 report24 earlier reportsnormal: 2.1M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 25 Mar 2023

Albemarle had 5.5M shares sold short in the 15 Mar 2023 report, 3.3× the same report last year.

This period
5.5M (the 15 Mar 2023 report)
Normal report (median of 24 earlier)
2.2M
Typical spread (median absolute deviation)
380K
How far from its usual level
+5.8
Same report last year
1.6M
History used
1,902 days
2022-03-15: 1.6M2022-03-31: 1.5M2022-04-14: 1.6M2022-04-29: 1.5M2022-05-13: 1.8M2022-05-31: 1.9M2022-06-15: 2.1M2022-06-30: 2.0M2022-07-15: 2.2M2022-07-29: 2.3M2022-08-15: 2.6M2022-08-31: 2.5M2022-09-15: 2.7M2022-09-30: 2.5M2022-10-14: 2.2M2022-10-31: 2.1M2022-11-15: 2.0M2022-11-30: 2.1M2022-12-15: 2.9M2022-12-30: 3.4M2023-01-13: 3.6M2023-01-31: 4.0M2023-02-15: 4.0M2023-02-28: 5.3M2023-03-15: 5.5M
the 15 Mar 2023 report24 earlier reportsnormal: 2.2M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 13 Apr 2023

Albemarle had 6.2M shares sold short in the 31 Mar 2023 report, 4.2× the same report last year.

This period
6.2M (the 31 Mar 2023 report)
Normal report (median of 24 earlier)
2.3M
Typical spread (median absolute deviation)
417K
How far from its usual level
+6.4
Same report last year
1.5M
History used
1,918 days
2022-03-31: 1.5M2022-04-14: 1.6M2022-04-29: 1.5M2022-05-13: 1.8M2022-05-31: 1.9M2022-06-15: 2.1M2022-06-30: 2.0M2022-07-15: 2.2M2022-07-29: 2.3M2022-08-15: 2.6M2022-08-31: 2.5M2022-09-15: 2.7M2022-09-30: 2.5M2022-10-14: 2.2M2022-10-31: 2.1M2022-11-15: 2.0M2022-11-30: 2.1M2022-12-15: 2.9M2022-12-30: 3.4M2023-01-13: 3.6M2023-01-31: 4.0M2023-02-15: 4.0M2023-02-28: 5.3M2023-03-15: 5.5M2023-03-31: 6.2M
the 31 Mar 2023 report24 earlier reportsnormal: 2.3M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 26 Apr 2023

Albemarle had 6.9M shares sold short in the 14 Apr 2023 report, 4.4× the same report last year.

This period
6.9M (the 14 Apr 2023 report)
Normal report (median of 24 earlier)
2.4M
Typical spread (median absolute deviation)
433K
How far from its usual level
+7.1
Same report last year
1.6M
History used
1,932 days
2022-04-14: 1.6M2022-04-29: 1.5M2022-05-13: 1.8M2022-05-31: 1.9M2022-06-15: 2.1M2022-06-30: 2.0M2022-07-15: 2.2M2022-07-29: 2.3M2022-08-15: 2.6M2022-08-31: 2.5M2022-09-15: 2.7M2022-09-30: 2.5M2022-10-14: 2.2M2022-10-31: 2.1M2022-11-15: 2.0M2022-11-30: 2.1M2022-12-15: 2.9M2022-12-30: 3.4M2023-01-13: 3.6M2023-01-31: 4.0M2023-02-15: 4.0M2023-02-28: 5.3M2023-03-15: 5.5M2023-03-31: 6.2M2023-04-14: 6.9M
the 14 Apr 2023 report24 earlier reportsnormal: 2.4M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Financials: Quarterly revenue change became public on 9 May 2023

Albemarle reported revenue of $2.6B for the quarter ended 31 Mar 2023, 2.3× the same quarter last year.

This period
$2.6B (the quarter ended 31 Mar 2023)
Normal quarter (median of 8 earlier)
$1.0B
Typical spread (median absolute deviation)
$209.4M
How far from its usual level
+5.1
Same quarter last year
$1.1B
History used
5,022 days
2021-03-31: $829.3M2021-06-30: $773.9M2021-09-30: $830.6M2021-12-31: $894.2M2022-03-31: $1.1B2022-06-30: $1.5B2022-09-30: $2.1B2022-12-31: $2.6B2023-03-31: $2.6B
the quarter ended 31 Mar 20238 earlier quartersnormal: $1.0B

Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

Check it at the source: SEC EDGAR quarterly reports.

Insiders: Clustered insider buying became public on 16 May 2023

Albemarle had 3 insiders buy $1.5M of its shares on the open market within 30 days (3 filings).

Independent buyers
3
Purchase filings (Form 4, code P)
3
Total bought
$1.5M
Window
16 Apr 2023 to 16 May 2023

Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

Short interest and volume: Short interest spike became public on 10 May 2023

Albemarle had 5.5M shares sold short in the 28 Apr 2023 report, 3.7× the same report last year.

This period
5.5M (the 28 Apr 2023 report)
Normal report (median of 24 earlier)
2.5M
Typical spread (median absolute deviation)
456K
How far from its usual level
+4.5
Same report last year
1.5M
History used
1,946 days
2022-04-29: 1.5M2022-05-13: 1.8M2022-05-31: 1.9M2022-06-15: 2.1M2022-06-30: 2.0M2022-07-15: 2.2M2022-07-29: 2.3M2022-08-15: 2.6M2022-08-31: 2.5M2022-09-15: 2.7M2022-09-30: 2.5M2022-10-14: 2.2M2022-10-31: 2.1M2022-11-15: 2.0M2022-11-30: 2.1M2022-12-15: 2.9M2022-12-30: 3.4M2023-01-13: 3.6M2023-01-31: 4.0M2023-02-15: 4.0M2023-02-28: 5.3M2023-03-15: 5.5M2023-03-31: 6.2M2023-04-14: 6.9M2023-04-28: 5.5M
the 28 Apr 2023 report24 earlier reportsnormal: 2.5M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 25 May 2023

Albemarle had 6.0M shares sold short in the 15 May 2023 report, 3.3× the same report last year.

This period
6.0M (the 15 May 2023 report)
Normal report (median of 24 earlier)
2.5M
Typical spread (median absolute deviation)
511K
How far from its usual level
+4.6
Same report last year
1.8M
History used
1,963 days
2022-05-13: 1.8M2022-05-31: 1.9M2022-06-15: 2.1M2022-06-30: 2.0M2022-07-15: 2.2M2022-07-29: 2.3M2022-08-15: 2.6M2022-08-31: 2.5M2022-09-15: 2.7M2022-09-30: 2.5M2022-10-14: 2.2M2022-10-31: 2.1M2022-11-15: 2.0M2022-11-30: 2.1M2022-12-15: 2.9M2022-12-30: 3.4M2023-01-13: 3.6M2023-01-31: 4.0M2023-02-15: 4.0M2023-02-28: 5.3M2023-03-15: 5.5M2023-03-31: 6.2M2023-04-14: 6.9M2023-04-28: 5.5M2023-05-15: 6.0M
the 15 May 2023 report24 earlier reportsnormal: 2.5M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 10 Jun 2023

Albemarle had 6.5M shares sold short in the 31 May 2023 report, 3.5× the same report last year.

This period
6.5M (the 31 May 2023 report)
Normal report (median of 24 earlier)
2.6M
Typical spread (median absolute deviation)
627K
How far from its usual level
+4.1
Same report last year
1.9M
History used
1,979 days
2022-05-31: 1.9M2022-06-15: 2.1M2022-06-30: 2.0M2022-07-15: 2.2M2022-07-29: 2.3M2022-08-15: 2.6M2022-08-31: 2.5M2022-09-15: 2.7M2022-09-30: 2.5M2022-10-14: 2.2M2022-10-31: 2.1M2022-11-15: 2.0M2022-11-30: 2.1M2022-12-15: 2.9M2022-12-30: 3.4M2023-01-13: 3.6M2023-01-31: 4.0M2023-02-15: 4.0M2023-02-28: 5.3M2023-03-15: 5.5M2023-03-31: 6.2M2023-04-14: 6.9M2023-04-28: 5.5M2023-05-15: 6.0M2023-05-31: 6.5M
the 31 May 2023 report24 earlier reportsnormal: 2.6M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Lobbying: Lobbying on a new issue became public on 3 Jul 2023

Albemarle lobbying on a new issue.

New
['FOR', 'MAN']
Rule
only points whose every posting (and value revision) is at or before as_of
Field
issue_codes
Metric
lobbying.filings_count
Point id
12620185

Government contracts: Federal obligations jump became public on 16 Jul 2023

Albemarle booked $149.7M in federal contract and grant obligations in June 2023, against none in the same month last year.

This period
$149.7M (June 2023)
Normal month (median of 5 earlier)
$0
Typical spread (median absolute deviation)
$344
How far from its usual level
+149.7
Same month last year
$0
History used
4,659 days
2018-06-01: $02019-06-01: $33K2020-06-01: $4582021-06-01: $02022-06-01: $02023-06-01: $149.7M
June 20235 earlier monthsnormal: $0

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least $5.0M.

Check it at the source: USAspending.gov award search.

Financials: Quarterly capital spending jump became public on 8 Aug 2023

Albemarle spent $503.7M on capital projects in the quarter ended 30 Jun 2023, 1.9× the same quarter last year.

This period
$503.7M (the quarter ended 30 Jun 2023)
Normal quarter (median of 8 earlier)
$285.9M
Typical spread (median absolute deviation)
$42.2M
How far from its usual level
+3.5
Same quarter last year
$270.9M
History used
4,839 days
2021-06-30: $217.2M2021-09-30: $255.8M2021-12-31: $300.9M2022-03-31: $231.7M2022-06-30: $270.9M2022-09-30: $313.3M2022-12-31: $445.7M2023-03-31: $415.6M2023-06-30: $503.7M
the quarter ended 30 Jun 20238 earlier quartersnormal: $285.9M

Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

Check it at the source: SEC EDGAR quarterly reports.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

26 May 2021confirmed

Confirmed across sources Institutional holdings and Lobbying

Albemarle (ALB): saw 112 13F filers open a new position in the quarter ended 31 Mar 2021, 1.8× the same quarter last year, while it lobbying on a new issue. Two unrelated kinds of activity within 7 days.

  • Institutional holdings: Many funds opening a new position, became public on 17 May 2021
  • Lobbying: Lobbying on a new issue, became public on 26 May 2021
2019-03-31: 662019-06-30: 542019-09-30: 412019-12-31: 672020-03-31: 632020-06-30: 842020-09-30: 652020-12-31: 1012021-03-31: 112
The quarter ended 31 Mar 2021 against the 8 quarters before it. this quarterearliernormal: 65.5
See the evidence (2 changes)

Institutional holdings: Many funds opening a new position became public on 17 May 2021

Albemarle saw 112 13F filers open a new position in the quarter ended 31 Mar 2021, 1.8× the same quarter last year.

This period
112 (the quarter ended 31 Mar 2021)
Normal quarter (median of 8 earlier)
65.5
Typical spread (median absolute deviation)
7
How far from its usual level
+4.5
Same quarter last year
63
History used
2,739 days
2019-03-31: 662019-06-30: 542019-09-30: 412019-12-31: 672020-03-31: 632020-06-30: 842020-09-30: 652020-12-31: 1012021-03-31: 112
the quarter ended 31 Mar 20218 earlier quartersnormal: 65.5

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

Check it at the source: SEC Form 13F data sets.

Lobbying: Lobbying on a new issue became public on 26 May 2021

Albemarle lobbying on a new issue.

New
['AUT', 'CSP', 'NAT']
Rule
only points whose every posting (and value revision) is at or before as_of
Field
issue_codes
Metric
lobbying.filings_count
Point id
12640116

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

Timeline

Changes and notable records, by the date each became public

  1. 30 Oct 2026Filings record

    A major agreement ended

  2. 3 Sep 2026Filings record

    Director or officer change

  3. 21 Aug 2026Filings record

    Director or officer change

  4. 23 Jul 2026Filings record

    Director or officer change

  5. 5 Jun 2026Filings record

    Director or officer change

  6. 15 May 2026Institutional holdings change

    saw 165 13F filers open a new position in the quarter ended 31 Mar 2026, 2.1× the same quarter last year.

    Same quarter last year: 77; its normal quarter is 87.5.

    See the evidence
    This period
    165 (the quarter ended 31 Mar 2026)
    Normal quarter (median of 8 earlier)
    87.5
    Typical spread (median absolute deviation)
    10
    How far from its usual level
    +5.2
    Same quarter last year
    77
    History used
    4,565 days
    2024-03-31: 912024-06-30: 782024-09-30: 842024-12-31: 752025-03-31: 772025-06-30: 912025-09-30: 1302025-12-31: 1912026-03-31: 165
    the quarter ended 31 Mar 20268 earlier quartersnormal: 87.5

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  7. 8 May 2026Filings record

    Director or officer change

  8. 17 Apr 2026Filings record

    Director or officer change

  9. 6 Mar 2026Filings record

    Completed an acquisition or asset sale

  10. 4 Mar 2026Filings record

    Director or officer change

  11. 17 Feb 2026Institutional holdings change

    saw 191 13F filers open a new position in the quarter ended 31 Dec 2025, 2.5× the same quarter last year.

    Same quarter last year: 75; its normal quarter is 82.5.

    See the evidence
    This period
    191 (the quarter ended 31 Dec 2025)
    Normal quarter (median of 8 earlier)
    82.5
    Typical spread (median absolute deviation)
    6.5
    How far from its usual level
    +11.3
    Same quarter last year
    75
    History used
    4,475 days
    2023-12-31: 812024-03-31: 912024-06-30: 782024-09-30: 842024-12-31: 752025-03-31: 772025-06-30: 912025-09-30: 1302025-12-31: 191
    the quarter ended 31 Dec 20258 earlier quartersnormal: 82.5

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  12. 12 Dec 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  13. 12 Dec 2025Filings record

    Director or officer change

  14. 14 Nov 2025Institutional holdings change

    saw 130 13F filers open a new position in the quarter ended 30 Sep 2025, 1.5× the same quarter last year.

    Same quarter last year: 84; its normal quarter is 82.5.

    See the evidence
    This period
    130 (the quarter ended 30 Sep 2025)
    Normal quarter (median of 8 earlier)
    82.5
    Typical spread (median absolute deviation)
    6.5
    How far from its usual level
    +4.9
    Same quarter last year
    84
    History used
    4,383 days
    2023-09-30: 1002023-12-31: 812024-03-31: 912024-06-30: 782024-09-30: 842024-12-31: 752025-03-31: 772025-06-30: 912025-09-30: 130
    the quarter ended 30 Sep 20258 earlier quartersnormal: 82.5

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  15. 27 Oct 2025Filings record

    Asset write-down (impairment)

  16. 12 Aug 2025Filings record

    Director or officer change

  17. 4 Aug 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  18. 4 Aug 2025Filings record

    Director or officer change

  19. 26 Jun 2025Short interest and volume change

    had 18.7M shares sold short in the 13 Jun 2025 report, 1.1× the same report last year.

    Same report last year: 17.1M; its normal report is 13.2M.

    See the evidence
    This period
    18.7M (the 13 Jun 2025 report)
    Normal report (median of 24 earlier)
    13.2M
    Typical spread (median absolute deviation)
    938K
    How far from its usual level
    +4.0
    Same report last year
    17.1M
    History used
    2,723 days
    2024-06-14: 17.1M2024-06-28: 15.5M2024-07-15: 14.6M2024-07-31: 14.5M2024-08-15: 12.3M2024-08-30: 11.9M2024-09-13: 13.7M2024-09-30: 12.2M2024-10-15: 13.7M2024-10-31: 13.6M2024-11-15: 12.3M2024-11-29: 12.7M2024-12-13: 13.2M2024-12-31: 13.2M2025-01-15: 13.2M2025-01-31: 13.2M2025-02-14: 11.2M2025-02-28: 12.0M2025-03-14: 12.8M2025-03-31: 13.0M2025-04-15: 14.4M2025-04-30: 17.1M2025-05-15: 18.8M2025-05-30: 18.6M2025-06-13: 18.7M
    the 13 Jun 2025 report24 earlier reportsnormal: 13.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  20. 11 Jun 2025Short interest and volume change

    had 18.6M shares sold short in the 30 May 2025 report, 1.2× the same report last year.

    Same report last year: 15.9M; its normal report is 13.2M.

    See the evidence
    This period
    18.6M (the 30 May 2025 report)
    Normal report (median of 24 earlier)
    13.2M
    Typical spread (median absolute deviation)
    938K
    How far from its usual level
    +3.9
    Same report last year
    15.9M
    History used
    2,709 days
    2024-05-31: 15.9M2024-06-14: 17.1M2024-06-28: 15.5M2024-07-15: 14.6M2024-07-31: 14.5M2024-08-15: 12.3M2024-08-30: 11.9M2024-09-13: 13.7M2024-09-30: 12.2M2024-10-15: 13.7M2024-10-31: 13.6M2024-11-15: 12.3M2024-11-29: 12.7M2024-12-13: 13.2M2024-12-31: 13.2M2025-01-15: 13.2M2025-01-31: 13.2M2025-02-14: 11.2M2025-02-28: 12.0M2025-03-14: 12.8M2025-03-31: 13.0M2025-04-15: 14.4M2025-04-30: 17.1M2025-05-15: 18.8M2025-05-30: 18.6M
    the 30 May 2025 report24 earlier reportsnormal: 13.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  21. 28 May 2025Short interest and volume change

    had 18.8M shares sold short in the 15 May 2025 report, 1.4× the same report last year.

    Same report last year: 13.6M; its normal report is 13.2M.

    See the evidence
    This period
    18.8M (the 15 May 2025 report)
    Normal report (median of 24 earlier)
    13.2M
    Typical spread (median absolute deviation)
    880K
    How far from its usual level
    +4.3
    Same report last year
    13.6M
    History used
    2,694 days
    2024-05-15: 13.6M2024-05-31: 15.9M2024-06-14: 17.1M2024-06-28: 15.5M2024-07-15: 14.6M2024-07-31: 14.5M2024-08-15: 12.3M2024-08-30: 11.9M2024-09-13: 13.7M2024-09-30: 12.2M2024-10-15: 13.7M2024-10-31: 13.6M2024-11-15: 12.3M2024-11-29: 12.7M2024-12-13: 13.2M2024-12-31: 13.2M2025-01-15: 13.2M2025-01-31: 13.2M2025-02-14: 11.2M2025-02-28: 12.0M2025-03-14: 12.8M2025-03-31: 13.0M2025-04-15: 14.4M2025-04-30: 17.1M2025-05-15: 18.8M
    the 15 May 2025 report24 earlier reportsnormal: 13.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  22. 18 Apr 2025Lobbying record

    ALBEMARLE CORPORATION: new lobbying registration (BGR GOVERNMENT AFFAIRS) (dated 1 Apr 2025)

  23. 31 Oct 2024Filings record

    Director or officer change

  24. 7 Oct 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  25. 7 Oct 2024Filings record

    Director or officer change

  26. 10 Feb 2024Short interest and volume change

    had 13.9M shares sold short in the 31 Jan 2024 report, 3.5× the same report last year.

    Same report last year: 4.0M; its normal report is 6.8M.

    See the evidence
    This period
    13.9M (the 31 Jan 2024 report)
    Normal report (median of 24 earlier)
    6.8M
    Typical spread (median absolute deviation)
    1.3M
    How far from its usual level
    +3.6
    Same report last year
    4.0M
    History used
    2,224 days
    2023-01-31: 4.0M2023-02-15: 4.0M2023-02-28: 5.3M2023-03-15: 5.5M2023-03-31: 6.2M2023-04-14: 6.9M2023-04-28: 5.5M2023-05-15: 6.0M2023-05-31: 6.5M2023-06-15: 6.6M2023-06-30: 7.5M2023-07-14: 6.4M2023-07-31: 5.9M2023-08-15: 6.5M2023-08-31: 7.7M2023-09-15: 8.5M2023-09-29: 8.8M2023-10-13: 9.2M2023-10-31: 9.0M2023-11-15: 11.5M2023-11-30: 13.1M2023-12-15: 12.1M2023-12-29: 14.1M2024-01-12: 14.1M2024-01-31: 13.9M
    the 31 Jan 2024 report24 earlier reportsnormal: 6.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  27. 25 Jan 2024Short interest and volume change

    had 14.1M shares sold short in the 12 Jan 2024 report, 3.9× the same report last year.

    Same report last year: 3.6M; its normal report is 6.5M.

    See the evidence
    This period
    14.1M (the 12 Jan 2024 report)
    Normal report (median of 24 earlier)
    6.5M
    Typical spread (median absolute deviation)
    1.2M
    How far from its usual level
    +4.4
    Same report last year
    3.6M
    History used
    2,205 days
    2023-01-13: 3.6M2023-01-31: 4.0M2023-02-15: 4.0M2023-02-28: 5.3M2023-03-15: 5.5M2023-03-31: 6.2M2023-04-14: 6.9M2023-04-28: 5.5M2023-05-15: 6.0M2023-05-31: 6.5M2023-06-15: 6.6M2023-06-30: 7.5M2023-07-14: 6.4M2023-07-31: 5.9M2023-08-15: 6.5M2023-08-31: 7.7M2023-09-15: 8.5M2023-09-29: 8.8M2023-10-13: 9.2M2023-10-31: 9.0M2023-11-15: 11.5M2023-11-30: 13.1M2023-12-15: 12.1M2023-12-29: 14.1M2024-01-12: 14.1M
    the 12 Jan 2024 report24 earlier reportsnormal: 6.5M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  28. 23 Jan 2024several at once

    had 14.1M shares sold short in the 29 Dec 2023 report, 4.2× the same report last year, while it reported $430K of lobbying spend for the quarter ended 31 Dec 2023, 17× the same quarter last year. Two unrelated kinds of activity within 28 days.

    See the evidence (4 changes)

    Short interest and volume: Short interest spike became public on 11 Jan 2024

    Albemarle had 14.1M shares sold short in the 29 Dec 2023 report, 4.2× the same report last year.

    This period
    14.1M (the 29 Dec 2023 report)
    Normal report (median of 24 earlier)
    6.5M
    Typical spread (median absolute deviation)
    1.2M
    How far from its usual level
    +4.4
    Same report last year
    3.4M
    History used
    2,191 days
    2022-12-30: 3.4M2023-01-13: 3.6M2023-01-31: 4.0M2023-02-15: 4.0M2023-02-28: 5.3M2023-03-15: 5.5M2023-03-31: 6.2M2023-04-14: 6.9M2023-04-28: 5.5M2023-05-15: 6.0M2023-05-31: 6.5M2023-06-15: 6.6M2023-06-30: 7.5M2023-07-14: 6.4M2023-07-31: 5.9M2023-08-15: 6.5M2023-08-31: 7.7M2023-09-15: 8.5M2023-09-29: 8.8M2023-10-13: 9.2M2023-10-31: 9.0M2023-11-15: 11.5M2023-11-30: 13.1M2023-12-15: 12.1M2023-12-29: 14.1M
    the 29 Dec 2023 report24 earlier reportsnormal: 6.5M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Lobbying: Lobbying spend jump became public on 19 Jan 2024

    Albemarle reported $430K of lobbying spend for the quarter ended 31 Dec 2023, 17× the same quarter last year.

    This period
    $430K (the quarter ended 31 Dec 2023)
    Normal quarter (median of 8 earlier)
    $25K
    Typical spread (median absolute deviation)
    $0
    How far from its usual level
    +20.2
    Same quarter last year
    $25K
    History used
    5,297 days
    2021-12-31: $25K2022-03-31: $25K2022-06-30: $25K2022-09-30: $25K2022-12-31: $25K2023-03-31: $260K2023-06-30: $320K2023-09-30: $430K2023-12-31: $430K
    the quarter ended 31 Dec 20238 earlier quartersnormal: $25K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least $100K.

    Check it at the source: Senate/House lobbying disclosures (LDA).

    Short interest and volume: Short interest spike became public on 25 Jan 2024

    Albemarle had 14.1M shares sold short in the 12 Jan 2024 report, 3.9× the same report last year.

    This period
    14.1M (the 12 Jan 2024 report)
    Normal report (median of 24 earlier)
    6.5M
    Typical spread (median absolute deviation)
    1.2M
    How far from its usual level
    +4.4
    Same report last year
    3.6M
    History used
    2,205 days
    2023-01-13: 3.6M2023-01-31: 4.0M2023-02-15: 4.0M2023-02-28: 5.3M2023-03-15: 5.5M2023-03-31: 6.2M2023-04-14: 6.9M2023-04-28: 5.5M2023-05-15: 6.0M2023-05-31: 6.5M2023-06-15: 6.6M2023-06-30: 7.5M2023-07-14: 6.4M2023-07-31: 5.9M2023-08-15: 6.5M2023-08-31: 7.7M2023-09-15: 8.5M2023-09-29: 8.8M2023-10-13: 9.2M2023-10-31: 9.0M2023-11-15: 11.5M2023-11-30: 13.1M2023-12-15: 12.1M2023-12-29: 14.1M2024-01-12: 14.1M
    the 12 Jan 2024 report24 earlier reportsnormal: 6.5M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 10 Feb 2024

    Albemarle had 13.9M shares sold short in the 31 Jan 2024 report, 3.5× the same report last year.

    This period
    13.9M (the 31 Jan 2024 report)
    Normal report (median of 24 earlier)
    6.8M
    Typical spread (median absolute deviation)
    1.3M
    How far from its usual level
    +3.6
    Same report last year
    4.0M
    History used
    2,224 days
    2023-01-31: 4.0M2023-02-15: 4.0M2023-02-28: 5.3M2023-03-15: 5.5M2023-03-31: 6.2M2023-04-14: 6.9M2023-04-28: 5.5M2023-05-15: 6.0M2023-05-31: 6.5M2023-06-15: 6.6M2023-06-30: 7.5M2023-07-14: 6.4M2023-07-31: 5.9M2023-08-15: 6.5M2023-08-31: 7.7M2023-09-15: 8.5M2023-09-29: 8.8M2023-10-13: 9.2M2023-10-31: 9.0M2023-11-15: 11.5M2023-11-30: 13.1M2023-12-15: 12.1M2023-12-29: 14.1M2024-01-12: 14.1M2024-01-31: 13.9M
    the 31 Jan 2024 report24 earlier reportsnormal: 6.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

  29. 19 Jan 2024Lobbying change

    reported $430K of lobbying spend for the quarter ended 31 Dec 2023, 17× the same quarter last year.

    Same quarter last year: $25K; its normal quarter is $25K.

    See the evidence
    This period
    $430K (the quarter ended 31 Dec 2023)
    Normal quarter (median of 8 earlier)
    $25K
    Typical spread (median absolute deviation)
    $0
    How far from its usual level
    +20.2
    Same quarter last year
    $25K
    History used
    5,297 days
    2021-12-31: $25K2022-03-31: $25K2022-06-30: $25K2022-09-30: $25K2022-12-31: $25K2023-03-31: $260K2023-06-30: $320K2023-09-30: $430K2023-12-31: $430K
    the quarter ended 31 Dec 20238 earlier quartersnormal: $25K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least $100K.

    Check it at the source: Senate/House lobbying disclosures (LDA).

  30. 11 Jan 2024Short interest and volume change

    had 14.1M shares sold short in the 29 Dec 2023 report, 4.2× the same report last year.

    Same report last year: 3.4M; its normal report is 6.5M.

    See the evidence
    This period
    14.1M (the 29 Dec 2023 report)
    Normal report (median of 24 earlier)
    6.5M
    Typical spread (median absolute deviation)
    1.2M
    How far from its usual level
    +4.4
    Same report last year
    3.4M
    History used
    2,191 days
    2022-12-30: 3.4M2023-01-13: 3.6M2023-01-31: 4.0M2023-02-15: 4.0M2023-02-28: 5.3M2023-03-15: 5.5M2023-03-31: 6.2M2023-04-14: 6.9M2023-04-28: 5.5M2023-05-15: 6.0M2023-05-31: 6.5M2023-06-15: 6.6M2023-06-30: 7.5M2023-07-14: 6.4M2023-07-31: 5.9M2023-08-15: 6.5M2023-08-31: 7.7M2023-09-15: 8.5M2023-09-29: 8.8M2023-10-13: 9.2M2023-10-31: 9.0M2023-11-15: 11.5M2023-11-30: 13.1M2023-12-15: 12.1M2023-12-29: 14.1M
    the 29 Dec 2023 report24 earlier reportsnormal: 6.5M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  31. 12 Dec 2023Short interest and volume change

    had 13.1M shares sold short in the 30 Nov 2023 report, 6.2× the same report last year.

    Same report last year: 2.1M; its normal report is 6.3M.

    See the evidence
    This period
    13.1M (the 30 Nov 2023 report)
    Normal report (median of 24 earlier)
    6.3M
    Typical spread (median absolute deviation)
    1.3M
    How far from its usual level
    +3.6
    Same report last year
    2.1M
    History used
    2,162 days
    2022-11-30: 2.1M2022-12-15: 2.9M2022-12-30: 3.4M2023-01-13: 3.6M2023-01-31: 4.0M2023-02-15: 4.0M2023-02-28: 5.3M2023-03-15: 5.5M2023-03-31: 6.2M2023-04-14: 6.9M2023-04-28: 5.5M2023-05-15: 6.0M2023-05-31: 6.5M2023-06-15: 6.6M2023-06-30: 7.5M2023-07-14: 6.4M2023-07-31: 5.9M2023-08-15: 6.5M2023-08-31: 7.7M2023-09-15: 8.5M2023-09-29: 8.8M2023-10-13: 9.2M2023-10-31: 9.0M2023-11-15: 11.5M2023-11-30: 13.1M
    the 30 Nov 2023 report24 earlier reportsnormal: 6.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  32. 8 Nov 2023Insiders record

    Coleman Kristin M. (EVP, General Counsel) bought 1,373 shares of ALB ($167,314) (dated 7 Nov 2023)

  33. 26 Oct 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  34. 26 Oct 2023Filings record

    Director or officer change

  35. 8 Aug 2023Financials change

    spent $503.7M on capital projects in the quarter ended 30 Jun 2023, 1.9× the same quarter last year.

    Same quarter last year: $270.9M; its normal quarter is $285.9M.

    See the evidence
    This period
    $503.7M (the quarter ended 30 Jun 2023)
    Normal quarter (median of 8 earlier)
    $285.9M
    Typical spread (median absolute deviation)
    $42.2M
    How far from its usual level
    +3.5
    Same quarter last year
    $270.9M
    History used
    4,839 days
    2021-06-30: $217.2M2021-09-30: $255.8M2021-12-31: $300.9M2022-03-31: $231.7M2022-06-30: $270.9M2022-09-30: $313.3M2022-12-31: $445.7M2023-03-31: $415.6M2023-06-30: $503.7M
    the quarter ended 30 Jun 20238 earlier quartersnormal: $285.9M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  36. 16 Jul 2023Government contracts change

    booked $149.7M in federal contract and grant obligations in June 2023, against none in the same month last year.

    See the evidence
    This period
    $149.7M (June 2023)
    Normal month (median of 5 earlier)
    $0
    Typical spread (median absolute deviation)
    $344
    How far from its usual level
    +149.7
    Same month last year
    $0
    History used
    4,659 days
    2018-06-01: $02019-06-01: $33K2020-06-01: $4582021-06-01: $02022-06-01: $02023-06-01: $149.7M
    June 20235 earlier monthsnormal: $0

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 9+ earlier periods, 365+ days of history and a value of at least $5.0M.

    Check it at the source: USAspending.gov award search.

  37. 16 Jul 2023Government contracts record

    ALBEMARLE U.S., INC.: new Department of Energy grant DEMS0000001 ($149.7M) (dated 15 Jun 2023)

  38. 3 Jul 2023Lobbying change

    lobbying on a new issue.

    See the evidence
    New
    ['FOR', 'MAN']
    Rule
    only points whose every posting (and value revision) is at or before as_of
    Field
    issue_codes
    Metric
    lobbying.filings_count
    Point id
    12620185
  39. 3 Jul 2023Lobbying record

    ALBEMARLE CORPORATION: lobbying engagement terminated (in-house) (dated 1 Apr 2023)

  40. 10 Jun 2023Short interest and volume change

    had 6.5M shares sold short in the 31 May 2023 report, 3.5× the same report last year.

    Same report last year: 1.9M; its normal report is 2.6M.

    See the evidence
    This period
    6.5M (the 31 May 2023 report)
    Normal report (median of 24 earlier)
    2.6M
    Typical spread (median absolute deviation)
    627K
    How far from its usual level
    +4.1
    Same report last year
    1.9M
    History used
    1,979 days
    2022-05-31: 1.9M2022-06-15: 2.1M2022-06-30: 2.0M2022-07-15: 2.2M2022-07-29: 2.3M2022-08-15: 2.6M2022-08-31: 2.5M2022-09-15: 2.7M2022-09-30: 2.5M2022-10-14: 2.2M2022-10-31: 2.1M2022-11-15: 2.0M2022-11-30: 2.1M2022-12-15: 2.9M2022-12-30: 3.4M2023-01-13: 3.6M2023-01-31: 4.0M2023-02-15: 4.0M2023-02-28: 5.3M2023-03-15: 5.5M2023-03-31: 6.2M2023-04-14: 6.9M2023-04-28: 5.5M2023-05-15: 6.0M2023-05-31: 6.5M
    the 31 May 2023 report24 earlier reportsnormal: 2.6M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

Showing the newest 40 of 122 entries; narrow the window or the kind of data to see older ones.

Not listed: 215 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0000915913
Ticker
ALB
Domain
albemarle.com
Employer name
albermarle, Albemarle Corporation (1 unverified)
Hq location
NC|CHARLOTTE|28209 (1 unverified)
Lobbying client
albemarle
Name
ACI Cyprus, L.L.C, Albemarle Amendments, LLC, Albemarle Argentina S.R.L, Albemarle Chemical Canada Ltd and 88 more
Uei
JRMZW5N52D89
Wikidata
Q127074
Wikipedia
Albemarle Corporation
  • DOL H-1B labor condition applications and PERM certifications166 data points28 Oct 2019 to 8 Jun 2026
  • Federal lobbying disclosures (LDA)11 records, 257 data points30 Jun 1999 to 30 Sep 2026
  • SEC Form 13F institutional holdings2 records, 481 data points30 Jun 2013 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)169 records26 Jan 2016 to 4 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)1170 data points31 Dec 2007 to 28 Oct 2026
  • SEC Form 4 insider transactions97 records, 296 data points7 Jan 2016 to 19 May 2026
  • FINRA short interest (twice monthly)636 data points29 Dec 2017 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026
  • USASpending.gov federal awards2 records, 228 data points27 Sep 2010 to 10 Mar 2026
  • Wikipedia pageviews2882 data points1 Jan 2019 to 21 Nov 2026